Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T

NCT03339661 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT03339661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03339661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Prophylaxis After CMV Disease in Kidney Transplant Patients Targeted by γδ T
Lead sponsor
University Hospital, Bordeaux
Phase
Phase 2
Overall status
Completed
Start date
November 23, 2017
Completion date
November 23, 2020
Enrollment
38 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant infection